Tablet
Latest AstraZeneca AB Patents:
- Substituted 6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidines, 5,7-dihydrofuro[3,4-d]pyrimidines, and pyrido[2,3-d]pyrimidines as KCC2 modulators
- Graph construction and visualization of multiplex immunofluorescence images
- Apparatus and method for evaluating physical strength or robustness of solid pharmaceutical dosage forms based on an impact strike test
- Chemical compounds
- Medical injector
Description
Claims
The ornamental design for a tablet, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
| 4439195 | March 27, 1984 | Swanson et al. |
| D377086 | December 31, 1996 | Tortarolo |
| D430285 | August 29, 2000 | Chen et al. |
| D437407 | February 6, 2001 | Burrows |
| D493518 | July 27, 2004 | McAllister et al. |
| D506545 | June 21, 2005 | McAllister et al. |
| 7029699 | April 18, 2006 | Robinson et al. |
| D564086 | March 11, 2008 | Nielsen et al. |
| D601689 | October 6, 2009 | Karolak et al. |
- U.S. Appl. No. 29/356,484, filed Feb. 26, 2010.
Patent History
Patent number: D636070
Type: Grant
Filed: Feb 26, 2010
Date of Patent: Apr 12, 2011
Assignee: AstraZeneca AB (Södertälje)
Inventors: Tove Illing (Macclesfield), Johan Janner (Södertälje), Jonathan Sutch (Loughborough)
Primary Examiner: Charles A Rademaker
Attorney: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Application Number: 29/356,485
Type: Grant
Filed: Feb 26, 2010
Date of Patent: Apr 12, 2011
Assignee: AstraZeneca AB (Södertälje)
Inventors: Tove Illing (Macclesfield), Johan Janner (Södertälje), Jonathan Sutch (Loughborough)
Primary Examiner: Charles A Rademaker
Attorney: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Application Number: 29/356,485
Classifications
Current U.S. Class:
Tablet Or Caplet (1) (D24/101)